70% to 90% of the country would need to vaccinate against COVID-19 to achieve herd immunity.
In the race to develop a vaccine to stop the novel coronavirus that’s killed more than half a million people and crippled economies across the globe, we may be overlooking one very important question: Will people actually want to get the vaccine if one becomes available?
Now a new survey from a collaboration by Harvard, Rutgers, Northeastern and Northwestern universities digs even deeper into why some people are ready to give a future coronavirus vaccine a shot, and why others are much more skittish. And the willingness to get vaccinated differs greatly based on where people live, their political party and several social factors, including income.
What’s more, while 67% of white Americans, 71% of Hispanics and 77% of Asian American respondents said they were likely to get the future vaccine, barely half of African American respondents agreed — even though the minority population has been hit especially hard by the virus. And this aligns with a Reuters/Ipsos poll from May that found that only half of Black Americans were somewhat or very interested in a vaccine.
The researchers found one notable exception to the trust rule, however, and that was President Donald Trump. People with the greatest trust in Trump were the least likely to seek vaccination , while those with the least trust in him were more likely to get vaccinated. Three in four Democrats surveyed also said they would likely get vaccinated, compared to Republicans and Independents, who were both at 62%.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Goldman Sachs says investors are underestimating the chance of a COVID-19 vaccine in 2020, an event that could push the S&P 500 11% higher | Markets InsiderGoldman Sachs thinks markets are underpricing the prospect that at least one coronavirus vaccine will be developed and ready for use by the end ...
Weiterlesen »
FDA Adviser: Not Realistic To Expect A COVID-19 Vaccine In 2020Dr. Paul Offit, who serves on the Food and Drug Administration's vaccine advisory board, says he doesn't think an effective vaccine that's undergone adequate testing can be ready this year.
Weiterlesen »
Factbox: AstraZeneca's potential coronavirus vaccineAstraZeneca signed its first COVID-19 vaccine supply deal with a Chinese company, Kangtai Bio, on Thursday, opening up distribution to one of the world's most populous countries.
Weiterlesen »
Early Coronavirus Vaccine Supplies Likely Won’t Be Enough for Everyone at High RiskInitial supplies of any successful coronavirus vaccines are now expected to fall short of what is needed, forcing drugmakers and U.S. officials to grapple with the thorny question of who should be first in line.
Weiterlesen »
Dems want expert panel to OK coronavirus vaccine before mass useFirst on ABC News: House Democrats call on the Food and Drug Administration to empower an independent panel of experts to review and sign off before a coronavirus vaccine is distributed to the general public.
Weiterlesen »